Joint Statement on Strengthening the Antibiotic R&D Pipeline by Rewarding Innovation

  20 November 2021

The emerging threat of antimicrobial resistance (AMR) for public health worldwide is not only
concerning during the COVID-19 pandemic, but will become even more alarming after the current
global health crisis. To combat this threat, no single actor or actor group can deliver a solution
alone. A partnership approach with both the public and private sector is essential to successfully
address the public health impact of AMR. There is a high unmet need for innovative antibiotics that
either overcome resistances and/or offer novel treatment options to yet untargeted pathogens and
to serve the needs of particularly vulnerable populations, especially children and neonates. In addition, for already approved antibiotics the access-to-market transition and their rapid availability and
accessibility in high-burden countries must be much better ensured. Lastly, this goes together with
an appropriate use of antibiotics to avoid the emergence of new resistances (antibiotic stewardship).

Further reading: GARDP
Author(s): GARDP
Smart Innovations  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre


JSS University


Global Ambassador Network

Welcome at the AMR Insights Ambassador Network!

The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).

More information and free-of-charge registration
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!